http://www.uknetguide.co.uk/Latest-News/Diabetes-drug-may-treat-Alzheimers-800251268.html: "Experts believe that a drug commonly used to treat diabetes may provide a new therapy for Alzheimer's disease, the most common cause of dementia.
Metformin is an oral medicine used to help regulate blood sugar levels; its use is widespread thanks to its effectiveness and lack of serious side-effects."
Click on the title to see the index. Click on a post of interest and the link within the post for the rest of the article.
Wednesday, November 24, 2010
Friday, November 19, 2010
Biology of Autism
Biology of Autism: "A new window of opportunity for successful autism therapy has been discovered by researchers at University of California San Diego.
Alysson Muotri and colleagues made the discovery by first transforming adult cells taken from patients with Rett Syndrome into induced pluripotent stem cells."
Alysson Muotri and colleagues made the discovery by first transforming adult cells taken from patients with Rett Syndrome into induced pluripotent stem cells."
MRI scans show structural brain changes in people at Alzheimer`s risk
MRI scans show structural brain changes in people at Alzheimer`s risk: "A new study by neuroscientists at Rush University Medical Center suggest that people at risk of developing Alzheimer's disease exhibit a specific structural change in the brain that can be visualized by brain imaging.
The findings may help identify those who would most benefit from early intervention.
'One of the main challenges in the field of Alzheimer's disease is identifying individuals at risk of developing Alzheimer's disease so that therapeutic interventions developed in the future can be given at the earliest stage before symptoms begin to appear,' said Sarah George, a graduate student who co-authored the study with Leyla deToledo-Morrell, director of the graduate program in neuroscience at Rush University Medical Center and professor of neurological sciences at the Graduate College of Rush University"
The findings may help identify those who would most benefit from early intervention.
'One of the main challenges in the field of Alzheimer's disease is identifying individuals at risk of developing Alzheimer's disease so that therapeutic interventions developed in the future can be given at the earliest stage before symptoms begin to appear,' said Sarah George, a graduate student who co-authored the study with Leyla deToledo-Morrell, director of the graduate program in neuroscience at Rush University Medical Center and professor of neurological sciences at the Graduate College of Rush University"
Thursday, November 11, 2010
Latest Omega-3 Alzheimer’s Study report inaccurate | TopNews New Zealand
Latest Omega-3 Alzheimer’s Study report inaccurate TopNews New Zealand: "Chairman of Ocean Nutrition Canada, Robert Orr, is a fish oil company which observed that the fish oil wasn’t even used during the study and which makes it clear that the research was conducted with algal oil containing DHA only, and fish oil, on the othere hand contains both EPA and DHA.
He also said that DHA is definitely a very important part of the brain but the researchers should not have come to a conclusion that other fatty acids don’t play an important role in cognitive performance."
He also said that DHA is definitely a very important part of the brain but the researchers should not have come to a conclusion that other fatty acids don’t play an important role in cognitive performance."
Wednesday, November 10, 2010
Arthritis Drugs Linked to Lower Odds of Alzheimer's
Arthritis Drugs Linked to Lower Odds of Alzheimer's: "People who take drugs called TNF blockers for rheumatoid arthritis may potentially reduce their odds of developing Alzheimer's disease, preliminary research suggests.
The use of TNF blockers was associated with a 55% lower risk of Alzheimer's disease in people with rheumatoid arthritis, says Richard C. Chou, MD, PhD, of Dartmouth Medical School in Lebanon, N.H."
The use of TNF blockers was associated with a 55% lower risk of Alzheimer's disease in people with rheumatoid arthritis, says Richard C. Chou, MD, PhD, of Dartmouth Medical School in Lebanon, N.H."
Tuesday, November 9, 2010
Bilingualism can delay onset of Alzheimer`s symptoms by 5 yrs: Study
Bilingualism can delay onset of Alzheimer`s symptoms by 5 yrs: Study: "Baycrest's Rotman Research Institute has found that speaking two languages can help delay the onset of Alzheimer's symptoms by as much as five years.
'We are not claiming that bilingualism in any way prevents Alzheimer's or other dementias, but it may contribute to cognitive reserve in the brain which appears to delay the onset of Alzheimer's symptoms for quite some time,' said Dr. Fergus Craik, at the Rotman Research Institute."
'We are not claiming that bilingualism in any way prevents Alzheimer's or other dementias, but it may contribute to cognitive reserve in the brain which appears to delay the onset of Alzheimer's symptoms for quite some time,' said Dr. Fergus Craik, at the Rotman Research Institute."
Thursday, November 4, 2010
New drug may halt and even reverse Alzheimer`s effects
New drug may halt and even reverse Alzheimer`s effects: "Early trials of Kiovig have demonstrated that the new treatment had a significant stabilizing effect on people with the degenerative disease - halting the shrinkage of the brain and maintaining memory and speed of thought.
Now, Weill Cornell Medical Center in New York and the drug company Baxter International have launched a much larger trial to confirm the early results, reports the Telegraph.orbert Riedel, chief scientific officer of the company, said that the early results had been 'striking'."
Now, Weill Cornell Medical Center in New York and the drug company Baxter International have launched a much larger trial to confirm the early results, reports the Telegraph.orbert Riedel, chief scientific officer of the company, said that the early results had been 'striking'."
Wednesday, November 3, 2010
Fish Oil Supplements May Not Slow Alzheimer's
Fish Oil Supplements May Not Slow Alzheimer's: "One of the main components of fish oil doesn't help slow the development of symptoms in patients with early Alzheimer's, although experts aren't ruling out the possibility that supplementation given earlier might help prevent the disease.
The supplement, docosahexaenoic acid (DHA), is present in abundance in the brain and previous studies had suggested it might play a role in treatment."
The supplement, docosahexaenoic acid (DHA), is present in abundance in the brain and previous studies had suggested it might play a role in treatment."
Subscribe to:
Posts (Atom)